Clinical trials
Observational Pneumonia trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
36 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2013 | 1 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 8 |
| 2024 | 5 |
| 2025 | 5 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Recruiting | 9 |
| Not yet recruiting | 6 |
| Unknown status | 5 |
| Active, not recruiting | 3 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Guangzhou 8th People's Hospital | 3 |
| Peking University Third Hospital | 2 |
| Shanghai General Hospital, China | 2 |
| Zhonghao Fang | 2 |
| Bayer | 1 |
| Beijing Chao Yang Hospital | 1 |
| Children's Hospital of Fudan University | 1 |
| Children's Hospital of Hebei Province | 1 |
| China Academy of Chinese Medical Sciences | 1 |
| China National Center for Cardiovascular Diseases | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pneumonia | 36 |
| Sepsis | 4 |
| Acquired Immunodeficiency Syndrome | 3 |
| Infections | 3 |
| Bacterial Infections | 2 |
| Bronchitis | 2 |
| Disease | 2 |
| Pulmonary Disease, Chronic Obstructive | 2 |
| Adenocarcinoma | 1 |
| Bronchitis, Chronic | 1 |
Trials
Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.